• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从希拉毒蜥毒液中分离并鉴定艾塞那肽-4(一种艾塞那肽-3类似物)。豚鼠胰腺分散腺泡存在艾塞那肽受体的进一步证据。

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

作者信息

Eng J, Kleinman W A, Singh L, Singh G, Raufman J P

机构信息

Solomon A. Berson Research Laboratory, Veterans Affairs Medical Center, Bronx, New York 10468.

出版信息

J Biol Chem. 1992 Apr 15;267(11):7402-5.

PMID:1313797
Abstract

The recent identification in Heloderma horridum venom of exendin-3, a new member of the glucagon superfamily that acts as a pancreatic secretagogue, prompted a search for a similar peptide in Heloderma suspectum venom. An amino acid sequencing assay for peptides containing an amino-terminal histidine residue (His1) was used to isolate a 39-amino acid peptide, exendin-4, from H. suspectum venom. Exendin-4 differs from exendin-3 by two amino acid substitutions, Gly2-Glu3 in place of Ser2-Asp3, but is otherwise identical. The structural differences make exendin-4 distinct from exendin-3 in its bioactivity. In dispersed acini from guinea pig pancreas, natural and synthetic exendin-4 stimulate a monophasic increase in cAMP beginning at 100 pM that plateaus at 10 nM. The exendin-4-induced increase in cAMP is inhibited progressively by increasing concentrations of the exendin receptor antagonist, exendin-(9-39) amide. Unlike exendin-3, exendin-4 does not stimulate a second rise in acinar cAMP at concentrations greater than 100 nM, does not stimulate amylase release, and does not inhibit the binding of radiolabeled vasoactive intestinal peptide to acini. This indicates that in dispersed pancreatic acini, exendin-4 interacts only with the recently described exendin receptor.

摘要

近期在珠毒蜥毒液中发现了艾塞那肽-3,它是胰高血糖素超家族的新成员,可作为胰腺促分泌素,这促使人们在希拉毒蜥毒液中寻找类似肽。采用针对含有氨基末端组氨酸残基(His1)的肽的氨基酸测序分析方法,从希拉毒蜥毒液中分离出一种39个氨基酸的肽,即艾塞那肽-4。艾塞那肽-4与艾塞那肽-3有两个氨基酸替换差异,即Gly2-Glu3取代了Ser2-Asp3,但其他方面相同。结构差异使得艾塞那肽-4在生物活性上与艾塞那肽-3不同。在豚鼠胰腺的分散腺泡中,天然和合成的艾塞那肽-4在100 pM时开始刺激cAMP呈单相增加,并在10 nM时达到平稳。随着艾塞那肽受体拮抗剂艾塞那肽-(9-39)酰胺浓度的增加,艾塞那肽-4诱导的cAMP增加逐渐受到抑制。与艾塞那肽-3不同,艾塞那肽-4在浓度大于100 nM时不会刺激腺泡cAMP的第二次升高,不会刺激淀粉酶释放,也不会抑制放射性标记的血管活性肠肽与腺泡的结合。这表明在分散的胰腺腺泡中,艾塞那肽-4仅与最近描述的艾塞那肽受体相互作用。

相似文献

1
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.从希拉毒蜥毒液中分离并鉴定艾塞那肽-4(一种艾塞那肽-3类似物)。豚鼠胰腺分散腺泡存在艾塞那肽受体的进一步证据。
J Biol Chem. 1992 Apr 15;267(11):7402-5.
2
Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.截短的胰高血糖素样肽-1与豚鼠胰腺分散腺泡上的艾塞那肽受体相互作用。一种爬行动物肽艾塞那肽-4的哺乳动物类似物的鉴定。
J Biol Chem. 1992 Oct 25;267(30):21432-7.
3
Exendin-3, a novel peptide from Heloderma horridum venom, interacts with vasoactive intestinal peptide receptors and a newly described receptor on dispersed acini from guinea pig pancreas. Description of exendin-3(9-39) amide, a specific exendin receptor antagonist.艾塞那肽-3是一种来自毒蜥毒液的新型肽,它与血管活性肠肽受体以及豚鼠胰腺分散腺泡上一种新发现的受体相互作用。艾塞那肽-3(9-39)酰胺的描述,一种特异性艾塞那肽受体拮抗剂。
J Biol Chem. 1991 Feb 15;266(5):2897-902.
4
Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom.从毒蜥毒液中分离出的新型胰腺促分泌素艾塞那肽-3的纯化及结构
J Biol Chem. 1990 Nov 25;265(33):20259-62.
5
Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig.使用125I-[Y39]艾塞那肽-4来表征豚鼠分散胰腺腺泡和胃主细胞上的艾塞那肽受体。
Regul Pept. 1994 Aug 31;53(1):47-59. doi: 10.1016/0167-0115(94)90158-9.
6
Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini.艾塞那肽-4是一种来自可疑希拉毒蜥毒液的新型肽,它能增强胆囊收缩素诱导的大鼠胰腺腺泡淀粉酶释放。
Regul Pept. 1992 Sep 22;41(2):149-56. doi: 10.1016/0167-0115(92)90044-u.
7
Exendin peptides.艾塞那肽肽类
Mt Sinai J Med. 1992 Mar;59(2):147-9.
8
Actions of Gila monster venom on dispersed acini from guinea pig pancreas.吉拉毒蜥毒液对豚鼠胰腺分散腺泡的作用。
Am J Physiol. 1982 May;242(5):G470-4. doi: 10.1152/ajpgi.1982.242.5.G470.
9
Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum).从两种蜥蜴(毒蜥和危地马拉珠毒蜥)毒液中提取的肽类,如血管活性肠肽和肽组氨酸异亮氨酸酰胺的化学、免疫和生物学特性。
Eur J Biochem. 1987 Apr 15;164(2):321-7. doi: 10.1111/j.1432-1033.1987.tb11061.x.
10
Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.与血管活性肠肽(VIP)和促胰液素相关的肽与豚鼠胰腺腺泡的相互作用。
Am J Physiol. 1989 Feb;256(2 Pt 1):G283-90. doi: 10.1152/ajpgi.1989.256.2.G283.

引用本文的文献

1
Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists.关于胰高血糖素样肽-1(GLP-1)和GLP-1受体激动剂进入大脑的当前认识与争议
J Transl Int Med. 2025 Jun 20;13(3):201-210. doi: 10.1515/jtim-2025-0026. eCollection 2025 Jun.
2
Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications.下一代治疗用拟肽药物的进展:策略、修饰及应用
Chem Rev. 2025 Aug 13;125(15):7099-7166. doi: 10.1021/acs.chemrev.4c00989. Epub 2025 Jul 23.
3
Structure-Based Discovery of Orthosteric Non-Peptide GLP-1R Agonists via Integrated Virtual Screening and Molecular Dynamics.
通过整合虚拟筛选和分子动力学基于结构发现正构非肽类胰高血糖素样肽-1受体激动剂
Int J Mol Sci. 2025 Jun 26;26(13):6131. doi: 10.3390/ijms26136131.
4
Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application.肽配体激活的G蛋白偶联受体信号转导的结构见解:从分子机制到治疗应用
Exp Mol Med. 2025 Jul 8. doi: 10.1038/s12276-025-01497-y.
5
GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity.胰高血糖素样肽-1/胰高血糖素样肽-1受体轴:从代谢(肥胖症和2型糖尿病)到免疫
Open Biol. 2025 Jan;15(7):240303. doi: 10.1098/rsob.240303. Epub 2025 Jul 2.
6
GLP-1R Agonists and Their Therapeutic Potential in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases, a Systematic Review of the Literature.GLP-1受体激动剂及其在炎症性肠病和其他免疫介导的炎症性疾病中的治疗潜力:文献系统综述
Biomedicines. 2025 May 6;13(5):1128. doi: 10.3390/biomedicines13051128.
7
Case Report: A case of occult insulinoma localized by [F] FB (ePEG12)12-exendin-4 positron emission tomography with negative findings of selective arterial calcium stimulation test.病例报告:一例隐匿性胰岛素瘤通过[F] FB (ePEG12)12-艾塞那肽-4正电子发射断层扫描定位,选择性动脉钙刺激试验结果为阴性。
Front Endocrinol (Lausanne). 2025 May 8;16:1556813. doi: 10.3389/fendo.2025.1556813. eCollection 2025.
8
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.胰高血糖素样肽-1与下丘脑对饱腹感的调节:来自人类和动物研究的认知与神经学见解
Diabetes Metab J. 2025 May;49(3):333-347. doi: 10.4093/dmj.2025.0106. Epub 2025 May 1.
9
GLP-1 receptor agonists in the context of cancer: the road ahead.癌症背景下的胰高血糖素样肽-1受体激动剂:未来之路。
Am J Physiol Cell Physiol. 2025 Jun 1;328(6):C1822-C1828. doi: 10.1152/ajpcell.00245.2025. Epub 2025 Apr 26.
10
GLP-1-based therapies for diabetes, obesity and beyond.基于胰高血糖素样肽-1(GLP-1)的糖尿病、肥胖症及其他疾病治疗方法。
Nat Rev Drug Discov. 2025 Apr 25. doi: 10.1038/s41573-025-01183-8.